Makya - Generative AI for Drug Discovery

Makya, first generative platform designed chemists chemists, streamlines drug discovery creating diverse, novel, molecules that rapidly converge towards drug candidates. interface powered Makya Generative SaaS platform generates molecules your drug discovery project, easy interface made chemists chemists. Diverse, Novel & molecules, demand Makya ensures generation truly novel molecules incorporating Target Product Profile constraints from start, enabling rapid convergence towards viable drug candidates. Synthetic accessibility design leveraging commercial building blocks organic reactions, Makya allows synthesis constraints heart generation process. Iktos’ generative platform, mastered organic synthetic chemistry. Trained millions reactions, explores huge chemical space (1027) design novel molecules with optimized properties, faster. Import your project data & define your Target Product Profile Explore infinite possibilities offered Generative Select ideal optimized compounds, using scores Explore Makya accelerate your novo drug design process. Acceleration convergence drug candidate. Generation high value molecules based multi parametric optimization. Focus synthetic accessibility, ensuring send your compounds synthesis. Empower Medicinal chemist, facilitate Medchem & Compchem collaboration. Connection external models scoring functions enhanced flexibility. Discover Makya transformed drug discovery projects partners, delivering faster more efficient…